Glutathione S-transferases (GSTTI and GSTMI) gene deletions in Tunisians

Susceptibility and prognostic implications in breast carcinoma

A. Khedhaier, S. Remadi, M. Corbex, S. B. Ahmed, N. Bouaouina, S. Mestiri, R. Azaiez, A. N. Helal, Lotfi Chouchane

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Glutathione S-transferase Thetal and Mul (GSTT1 and GSTM1) are involved in the metabolism and detoxification of a wide range of potential environmental carcinogens. Conversely, they contribute to tumour cell survival by detoxification of numerous products induced by cancer therapy. The authors designed a large study to investigate the susceptibility and prognostic implications of the GSTT1 and GSTM1 gene deletions in breast carcinoma. The authors used the polymerase chain reaction to characterise the variation of the GSTT1 and GSTM1 genes in 309 unrelated Tunisian patients with breast carcinoma and 242 healthy control subjects. Associations of the clinic-pathologic parameters and the genetic markers with the rates of the breast carcinoma specific overall survival (OVS) and the disease-free survival (DFS) were assessed using univariate and multivariate analyses. A significant association was found between gene deletion of GSTT1 and the risk of early onset of breast carcinoma (OR = 1.60, P = 0.02). The lack of GSTT1 gene deletion was significantly associated with poor clinical response to chemotherapy (OR = 2.29, P = 0.03). This association was significantly higher in patients with axillary's lymph node-negative breast carcinoma (OR = 12.60, P = 0.005). The null-GSTT1 genotype showed a significant association with increased DFS in this selected population of patients. This association was even higher in patients carrying both null-GSTT1 and -GSTM1 genotypes. The gene deletion of GSTs may predict not only the early onset of breast carcinoma but also the clinical response to chemotherapy and the recurrence-free survival for patients with lymph node-negative breast carcinoma.

Original languageEnglish
Pages (from-to)1502-1507
Number of pages6
JournalBritish Journal of Cancer
Volume89
Issue number8
DOIs
Publication statusPublished - 20 Oct 2003
Externally publishedYes

Fingerprint

Gene Deletion
Glutathione Transferase
Breast Neoplasms
Disease-Free Survival
Lymph Nodes
Genotype
Environmental Carcinogens
Drug Therapy
Survival
Genetic Markers
Neoplasms
Cell Survival
Healthy Volunteers
Multivariate Analysis
Recurrence
Polymerase Chain Reaction
Population
Genes

Keywords

  • Breast carcinoma
  • GSTM1
  • GSTT1
  • Polymorphism
  • Prognosis
  • Susceptibility

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Glutathione S-transferases (GSTTI and GSTMI) gene deletions in Tunisians : Susceptibility and prognostic implications in breast carcinoma. / Khedhaier, A.; Remadi, S.; Corbex, M.; Ahmed, S. B.; Bouaouina, N.; Mestiri, S.; Azaiez, R.; Helal, A. N.; Chouchane, Lotfi.

In: British Journal of Cancer, Vol. 89, No. 8, 20.10.2003, p. 1502-1507.

Research output: Contribution to journalArticle

Khedhaier, A. ; Remadi, S. ; Corbex, M. ; Ahmed, S. B. ; Bouaouina, N. ; Mestiri, S. ; Azaiez, R. ; Helal, A. N. ; Chouchane, Lotfi. / Glutathione S-transferases (GSTTI and GSTMI) gene deletions in Tunisians : Susceptibility and prognostic implications in breast carcinoma. In: British Journal of Cancer. 2003 ; Vol. 89, No. 8. pp. 1502-1507.
@article{7ed41ccb52914bdbaa0d44736f809b06,
title = "Glutathione S-transferases (GSTTI and GSTMI) gene deletions in Tunisians: Susceptibility and prognostic implications in breast carcinoma",
abstract = "Glutathione S-transferase Thetal and Mul (GSTT1 and GSTM1) are involved in the metabolism and detoxification of a wide range of potential environmental carcinogens. Conversely, they contribute to tumour cell survival by detoxification of numerous products induced by cancer therapy. The authors designed a large study to investigate the susceptibility and prognostic implications of the GSTT1 and GSTM1 gene deletions in breast carcinoma. The authors used the polymerase chain reaction to characterise the variation of the GSTT1 and GSTM1 genes in 309 unrelated Tunisian patients with breast carcinoma and 242 healthy control subjects. Associations of the clinic-pathologic parameters and the genetic markers with the rates of the breast carcinoma specific overall survival (OVS) and the disease-free survival (DFS) were assessed using univariate and multivariate analyses. A significant association was found between gene deletion of GSTT1 and the risk of early onset of breast carcinoma (OR = 1.60, P = 0.02). The lack of GSTT1 gene deletion was significantly associated with poor clinical response to chemotherapy (OR = 2.29, P = 0.03). This association was significantly higher in patients with axillary's lymph node-negative breast carcinoma (OR = 12.60, P = 0.005). The null-GSTT1 genotype showed a significant association with increased DFS in this selected population of patients. This association was even higher in patients carrying both null-GSTT1 and -GSTM1 genotypes. The gene deletion of GSTs may predict not only the early onset of breast carcinoma but also the clinical response to chemotherapy and the recurrence-free survival for patients with lymph node-negative breast carcinoma.",
keywords = "Breast carcinoma, GSTM1, GSTT1, Polymorphism, Prognosis, Susceptibility",
author = "A. Khedhaier and S. Remadi and M. Corbex and Ahmed, {S. B.} and N. Bouaouina and S. Mestiri and R. Azaiez and Helal, {A. N.} and Lotfi Chouchane",
year = "2003",
month = "10",
day = "20",
doi = "10.1038/sj.bjc.6601292",
language = "English",
volume = "89",
pages = "1502--1507",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Glutathione S-transferases (GSTTI and GSTMI) gene deletions in Tunisians

T2 - Susceptibility and prognostic implications in breast carcinoma

AU - Khedhaier, A.

AU - Remadi, S.

AU - Corbex, M.

AU - Ahmed, S. B.

AU - Bouaouina, N.

AU - Mestiri, S.

AU - Azaiez, R.

AU - Helal, A. N.

AU - Chouchane, Lotfi

PY - 2003/10/20

Y1 - 2003/10/20

N2 - Glutathione S-transferase Thetal and Mul (GSTT1 and GSTM1) are involved in the metabolism and detoxification of a wide range of potential environmental carcinogens. Conversely, they contribute to tumour cell survival by detoxification of numerous products induced by cancer therapy. The authors designed a large study to investigate the susceptibility and prognostic implications of the GSTT1 and GSTM1 gene deletions in breast carcinoma. The authors used the polymerase chain reaction to characterise the variation of the GSTT1 and GSTM1 genes in 309 unrelated Tunisian patients with breast carcinoma and 242 healthy control subjects. Associations of the clinic-pathologic parameters and the genetic markers with the rates of the breast carcinoma specific overall survival (OVS) and the disease-free survival (DFS) were assessed using univariate and multivariate analyses. A significant association was found between gene deletion of GSTT1 and the risk of early onset of breast carcinoma (OR = 1.60, P = 0.02). The lack of GSTT1 gene deletion was significantly associated with poor clinical response to chemotherapy (OR = 2.29, P = 0.03). This association was significantly higher in patients with axillary's lymph node-negative breast carcinoma (OR = 12.60, P = 0.005). The null-GSTT1 genotype showed a significant association with increased DFS in this selected population of patients. This association was even higher in patients carrying both null-GSTT1 and -GSTM1 genotypes. The gene deletion of GSTs may predict not only the early onset of breast carcinoma but also the clinical response to chemotherapy and the recurrence-free survival for patients with lymph node-negative breast carcinoma.

AB - Glutathione S-transferase Thetal and Mul (GSTT1 and GSTM1) are involved in the metabolism and detoxification of a wide range of potential environmental carcinogens. Conversely, they contribute to tumour cell survival by detoxification of numerous products induced by cancer therapy. The authors designed a large study to investigate the susceptibility and prognostic implications of the GSTT1 and GSTM1 gene deletions in breast carcinoma. The authors used the polymerase chain reaction to characterise the variation of the GSTT1 and GSTM1 genes in 309 unrelated Tunisian patients with breast carcinoma and 242 healthy control subjects. Associations of the clinic-pathologic parameters and the genetic markers with the rates of the breast carcinoma specific overall survival (OVS) and the disease-free survival (DFS) were assessed using univariate and multivariate analyses. A significant association was found between gene deletion of GSTT1 and the risk of early onset of breast carcinoma (OR = 1.60, P = 0.02). The lack of GSTT1 gene deletion was significantly associated with poor clinical response to chemotherapy (OR = 2.29, P = 0.03). This association was significantly higher in patients with axillary's lymph node-negative breast carcinoma (OR = 12.60, P = 0.005). The null-GSTT1 genotype showed a significant association with increased DFS in this selected population of patients. This association was even higher in patients carrying both null-GSTT1 and -GSTM1 genotypes. The gene deletion of GSTs may predict not only the early onset of breast carcinoma but also the clinical response to chemotherapy and the recurrence-free survival for patients with lymph node-negative breast carcinoma.

KW - Breast carcinoma

KW - GSTM1

KW - GSTT1

KW - Polymorphism

KW - Prognosis

KW - Susceptibility

UR - http://www.scopus.com/inward/record.url?scp=0242490512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242490512&partnerID=8YFLogxK

U2 - 10.1038/sj.bjc.6601292

DO - 10.1038/sj.bjc.6601292

M3 - Article

VL - 89

SP - 1502

EP - 1507

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 8

ER -